{"date":"2026-04-06","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6576-2026-04-06-1122-1qewavl","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-04-06","time":"11:22:59","subject":"本公司前列腺癌新劑型新藥 CAMCEVI 21毫克獲加拿大上市許可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-04-06 11:22，「本公司前列腺癌新劑型新藥 CAMCEVI 21毫克獲加拿大上市許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}